Celly Announces Increase of Term Loan [Yahoo! Finance]
FSD Pharma Inc. - Class B Subordinate Voting Shares (HUGE)
Company Research
Source: Yahoo! Finance
into a loan amending agreement (the " Agreement ") in connection with the senior secured term loan made by FSD Pharma Inc. (" FSD Pharma ") to Celly Nu, as previously announced on their joint press release dated November 30, 2023 (the " Term Loan "), to increase the principal of the Term Loan by $300,000 to $1,300,000. Pursuant to the Agreement, the interest payment due on the first annual anniversary of the Term Loan will be deferred and become payable together with the interest payment due on the second annual anniversary of the Term Loan. Celly Nu will continue to make interest payments as required by the original loan agreement, as amended, in respect of the Term Loan, and will provide FSD Pharma the option to convert any amounts outstanding (inclusive of interest) into common shares of Celly Nu upon the occurrence of an event of default under the Agreement. The Term Loan continues to bear interest at 10% per annum payable on each anniversary and expires July 31, 2026. John Du
Show less
Read more
Impact Snapshot
Event Time:
HUGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HUGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HUGE alerts
High impacting FSD Pharma Inc. - Class B Subordinate Voting Shares news events
Weekly update
A roundup of the hottest topics
HUGE
News
- FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business ApplicationsAccesswire
- FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol IntoxicationAccesswire
- FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus InterestAccesswire
- FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol IntoxicationAccesswire
- FSD Pharma Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
HUGE
Analyst Actions
- 5/9/24 - Singular Research
HUGE
Sec Filings
- 6/13/24 - Form 6-K
- 6/4/24 - Form 6-K
- 5/31/24 - Form 6-K
- HUGE's page on the SEC website